Citations

1. Turpie AG, et al. (2002). Venous thromboembolism: Treatment strategies. BMJ, 325(7370): 948–951.

2. Ridker PM, et al. (2003). Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. New England Journal of Medicine, 348(15): 1425–1434.

3. Hyers TM (2003). Management of venous thromboembolism: Past, present, and future. Archives of Internal Medicine, 163(7): 759–768.

4. Kearon C, Hirsh J (2007). Venous thromboembolism. In DC Dale, DD Federman, eds., ACP Medicine, section 1, chap. 18. New York: WebMD.

5. Prandoni P, et al. (2004). Below-knee elastic compression stockings to prevent the post-thrombotic syndrome. Annals of Internal Medicine, 141(4): 249–256.

6. Seligsohn U, Lubetsky A (2001). Genetic susceptibility to venous thrombosis. New England Journal of Medicine, 344(16): 1222–1231.

7. Van Dongen CJJ, et al. (2007). Fixed-dose subcutaneous low-molecular-weight heparins versus adjusted-dose unfractionated heparin for venous thromboembolism. Cochrane Database of Systematic Reviews (2).

8. Hyers MT, et al. (2001). Antithrombotic therapy for venous thromboembolic disease. Sixth ACCP Consensus Conference on Antithrombotic Therapy. Chest, 119(1): 176S–193S.

9. Raskob GE, et al. (2006). Venous thrombosis. In MA Lichtman et al., eds., Williams Hematology, 7th ed., pp. 2055–2065. New York: McGraw-Hill.

10. Hirsh J, et al. (2001). Guide to anticoagulation therapy: Heparin. A statement for healthcare professionals from the American Heart Association. Circulation, 103(24): 2994–3018.

Other Works Consulted

• Snow V, et al. (2007). Management of venous thromboembolism: A clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Annals of Internal Medicine, 146(3): 204–210.

• Tapson VF, Becker RC (2007). Venous thromboembolism. In EJ Topol, ed., Textbook of Cardiovascular Medicine, 3rd ed., pp. 1569–1584. Philadelphia: Lippincott Williams and Wilkins.